Cochrane Abstracts
SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"SARS‐CoV‐2‐neutralising Monoclonal Antibodies to Prevent COVID‐19." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436525/1/Olanzapine_versus_other_atypical_antipsychotics_for_schizophrenia_Edited__no_change_to_conclusions_. Accessed 10 December 2023.
SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436525/1/Olanzapine_versus_other_atypical_antipsychotics_for_schizophrenia_Edited__no_change_to_conclusions_. Accessed December 10, 2023.
SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436525/1/Olanzapine_versus_other_atypical_antipsychotics_for_schizophrenia_Edited__no_change_to_conclusions_
SARS‐CoV‐2‐neutralising Monoclonal Antibodies to Prevent COVID‐19 [Internet]. In: Cochrane Abstracts. [cited 2023 December 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436525/1/Olanzapine_versus_other_atypical_antipsychotics_for_schizophrenia_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19
ID - 436525
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436525/1/Olanzapine_versus_other_atypical_antipsychotics_for_schizophrenia_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
